KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palantir Technologies (PLTR) Common Equity (2018 - 2025)

Palantir Technologies (PLTR) has disclosed Common Equity for 8 consecutive years, with $7.5 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 49.66% to $7.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 billion through Dec 2025, up 49.66% year-over-year, with the annual reading at $7.5 billion for FY2025, 49.66% up from the prior year.
  • Common Equity for Q4 2025 was $7.5 billion at Palantir Technologies, up from $6.6 billion in the prior quarter.
  • The five-year high for Common Equity was $7.5 billion in Q4 2025, with the low at $1.8 billion in Q1 2021.
  • Average Common Equity over 5 years is $3.7 billion, with a median of $3.2 billion recorded in 2023.
  • The sharpest move saw Common Equity skyrocketed 247.92% in 2021, then rose 6.16% in 2022.
  • Over 5 years, Common Equity stood at $2.3 billion in 2021, then grew by 15.34% to $2.6 billion in 2022, then skyrocketed by 34.76% to $3.6 billion in 2023, then surged by 40.5% to $5.0 billion in 2024, then soared by 49.66% to $7.5 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $7.5 billion, $6.6 billion, and $6.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.